APM
AXSM icon

Avidity Partners Management’s Axsome Therapeutics AXSM Stock Holding History

Avidity Partners Management’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-94,500
Closed -$9.86M – 46
2025
Q2 		$9.86M Buy
94,500
+17,500
+23% +$1.85M 1.97% 19
2025
Q1 		$8.98M Sell
77,000
-111,000
-59% -$12.6M 1.71% 20
2024
Q4 		$15.9M Sell
188,000
-108,100
-37% -$9.94M 1.56% 27
2024
Q3 		$26.6M Sell
296,100
-79,900
-21% -$6.97M 1.36% 30
2024
Q2 		$30.3M Sell
376,000
-55,000
-13% -$4.07M 1.29% 30
2024
Q1 		$34.4M Sell
431,000
-28,400
-6% -$2.38M 1.11% 35
2023
Q4 		$36.6M Buy
459,400
+162,600
+55% +$10.9M 1.33% 36
2023
Q3 		$20.7M Sell
296,800
-248,200
-46% -$18.6M 0.84% 47
2023
Q2 		$39.2M Sell
545,000
-74,200
-12% -$5.47M 1.37% 31
2023
Q1 		$38.2M Sell
619,200
-50,800
-8% -$3.34M 1.27% 29
2022
Q4 		$51.7M Sell
670,000
-868,600
-56% -$51.9M 1.12% 30
2022
Q3 		$68.7M Buy
+1,538,600
New +$76.9M 1.4% 25
2022
Q2 		– Sell
-711,000
Closed -$29.4M – 84
2022
Q1 		$29.4M Sell
711,000
-64,000
-8% -$1.98M 0.61% 43
2021
Q4 		$29.3M Buy
+775,000
New +$28.5M 0.62% 49
2020
Q4 		– Sell
-118,000
Closed -$8.41M – 101
2020
Q3 		$8.41M Sell
118,000
-286,900
-71% -$22.4M 0.39% 49
2020
Q2 		$33.3M Buy
404,900
+207,900
+106% +$16M 2.14% 14
2020
Q1 		$11.6M Buy
+197,000
New +$16.1M 1.6% 24

Other funds holding AXSM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Avidity Partners Management's AXSM Position: Q3 2025 in Review

Avidity Partners Management sold out of Axsome Therapeutics (AXSM) in Q3 2025, closing a stake of 94,500 shares — an estimated $9.86M sold.

Avidity Partners Management first reported a position in AXSM in Q1 2020 and held it in 17 quarters. The position peaked at $68.7M in Q3 2022. 355 funds tracked by Wall St. Rank hold AXSM as of Q3 2025.

  • Avidity Partners Management reported no remaining Axsome Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Avidity Partners Management sold 94,500 Axsome Therapeutics shares in Q3 2025, an estimated $9.86M.
  • Avidity Partners Management first reported a position in Axsome Therapeutics in Q1 2020 and held it in 17 quarters.
  • Avidity Partners Management's Axsome Therapeutics position peaked at $68.7M in Q3 2022.
  • 355 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q3 2025.

Based on Avidity Partners Management's 13F filing for Q3 2025, filed 14 Nov 2025.